Home › NDC Lookup › RxCUI directory › RxCUI 351285

Escitalopram 1 MG/ML Oral Solution — RxCUI 351285

RxNorm drug concept · Semantic clinical drug
RxCUI 351285 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351285
Official nameEscitalopram 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asescitalopram (as escitalopram oxalate) 5 MG per 5 ML Oral Solution; escitalopram 5 MG in 5 mL Oral Solution; escitalopram (as escitalopram oxalate) 10 MG per 10 ML Oral Solution
FDA products mapped11
Package NDCs mapped14
Reported Medicaid activity (SDUD)28,968 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Escitalopram: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's one of the most common questions — and honestly, antidepressants do take time. Most people don't notice a full effect in the first week or two. It often takes several weeks...
  • How long will it take before I start feeling better on escitalopram?
  • It's great that you're feeling better — but please don't stop on your own. Stopping escitalopram abruptly can cause withdrawal-like symptoms like dizziness, irritability, and a flu...
  • Can I stop taking escitalopram once I feel better?
📖 Read our full Escitalopram guide →

🕸️ Concept Web — How Escitalopram 1 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Escitalopram 1 MG/ML Oral Solution RxCUI 351285

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Escitalopram 321988
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Escitalopram Oral Solution 378734
    • Escitalopram Oral Liquid Product 1164520
    • Escitalopram Oral Product 1164521
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Escitalopram 1 MG/ML 353398

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Escitalopram 1 MG/ML SCDC · 353398
  • Escitalopram Oral Solution SCDF · 378734
  • Escitalopram Oral Liquid Product SCDG · 1164520
  • Escitalopram Oral Product SCDG · 1164521

📦 FDA Products & Package NDCs

11 products · 14 package NDCs
14 package NDCs map to RxCUI 351285 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00456-2005-01 100 TABLET, FILM COATED in 1 BOTTLE (0456-2005-01) Lexapro Allergan, Inc. 2002-08-14
00456-2010-01 100 TABLET, FILM COATED in 1 BOTTLE (0456-2010-01) Lexapro Allergan, Inc. 2002-08-14
00456-2020-01 100 TABLET, FILM COATED in 1 BOTTLE (0456-2020-01) Lexapro Allergan, Inc. 2002-08-14
16571-0769-24 240 mL in 1 BOTTLE (16571-769-24) Escitalopram Oxalate Rising Pharma Holdings, Inc. 2012-04-03
31722-0569-24 240 mL in 1 BOTTLE (31722-569-24) Escitalopram Oxalate Camber Pharmaceuticals, Inc. 2012-06-12
33342-0053-28 240 mL in 1 BOTTLE (33342-053-28) escitalopram Macleods Pharmaceuticals Limited 2016-03-31
51672-1348-01 1 BOTTLE in 1 CARTON (51672-1348-1) / 240 mL in 1 BOTTLE Escitalopram Sun Pharmaceutical Industries, Inc. 2012-05-03
51672-1348-08 1 BOTTLE in 1 CARTON (51672-1348-8) / 120 mL in 1 BOTTLE Escitalopram Sun Pharmaceutical Industries, Inc. 2012-05-03
51672-1348-09 1 BOTTLE in 1 CARTON (51672-1348-9) / 480 mL in 1 BOTTLE Escitalopram Sun Pharmaceutical Industries, Inc. 2012-05-03
62135-0729-24 2 TRAY in 1 BOX (62135-729-24) / 10 CUP in 1 TRAY / 10 mL i... Escitalopram Oral Solution Chartwell RX, LLC 2025-02-26
62135-0729-37 240 mL in 1 BOTTLE (62135-729-37) Escitalopram Oral Solution Chartwell RX, LLC 2023-08-11
65162-0705-88 240 mL in 1 BOTTLE (65162-705-88) Escitalopram Oxalate Amneal Pharmaceuticals LLC 2011-09-03
65862-0248-24 240 mL in 1 BOTTLE (65862-248-24) Escitalopram Oxalate Aurobindo Pharma Limited 2012-04-03
68999-0729-24 2 TRAY in 1 BOX (68999-729-24) / 10 CUP in 1 TRAY / 10 mL i... Escitalopram Oral Solution Chartwell Governmental & Specialty RX, LLC. 2026-01-21
Observed labelers: Allergan, Inc. (3) · Sun Pharmaceutical Industries, Inc. (3) · Chartwell RX, LLC (2) · Amneal Pharmaceuticals LLC (1) · Aurobindo Pharma Limited (1) · Camber Pharmaceuticals, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.